A New Medicine to Help Spinal Bones Fuse
Official title: Small Molecule Inhibition of Noggin to Induce Spinal Fusion
Funded at Emory University · NIH-11163278 · Data updated 2026-11-12
This research explores a new way to help spinal bones grow together by using a special medicine to reduce side effects often seen with current bone-healing treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | July 20, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $321,513 |
| NIH project number | 5R01AR078892-04 |
| Project ID | NIH-11163278 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is ultimately for patients who need spinal fusion surgery and are looking for options with potentially fewer side effects.
✕Less likely to help
Patients not undergoing spinal fusion or those seeking immediate treatment would not directly benefit from this early-stage research.
What this research studies
Current methods for spinal fusion often use proteins called BMPs to help bones grow, but these can sometimes lead to unwanted side effects like inflammation or nerve irritation. Our project is developing a new small molecule medicine designed to make spinal fusion safer and more effective. This medicine works by blocking a natural protein called noggin, which normally prevents bone growth, allowing lower amounts of bone-healing proteins to be used. The medicine will be delivered directly to the fusion site using a special scaffold, aiming to create a better environment for bones to fuse with fewer complications.
Why it matters
Potential benefit: If successful, this approach could lead to safer and more effective spinal fusion surgeries for patients, with fewer side effects than current treatments.
How similar studies have gone: Preliminary studies in animals have shown promising results for this new approach, though the specific small molecule inhibitor is a novel design.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Boden, Scott D. — Emory University
- Study coordinator: Boden, Scott D.
Related research
Other NIH-funded projects on the same topics.
-
Wireless metacages that measure spine fusion progress in real time
A tiny, wireless, self-powered cage grown into your spine could tell doctors how well your spinal fusion is progressing, without bulky hardware.
-
Small molecule block of noggin to improve spinal fusion
A promising approach to help spine fusion uses a tiny molecule to block noggin, allowing safer, lower doses of bone-building signals at the fusion site.
-
Flexible 3D‑printed spine cages to improve spinal fusion
This project tests whether softer, 3D‑printed spinal cages help bone fuse faster and hold up better for adults who need interbody spinal fusion.
-
Exploring how flexible spinal implants affect healing in the spine
This study is looking at new flexible spinal implants to see how they help with healing after surgery, which could lead to better recovery for people with back problems.
-
Blocking noggin to enhance spinal fusion
This study is exploring a new way to help your spine heal better after surgery by using a special material that helps encourage bone growth while reducing side effects, and it's showing good results in early tests with rabbits.
-
Understanding opioid misuse in adolescents after spinal surgery
This study is looking at how teens aged 12-18 handle pain after spinal fusion surgery and whether they might misuse opioids afterward, so we can find better ways to help them manage their pain safely.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.